123 related articles for article (PubMed ID: 27234455)
1. [Follow-up of patients treated by VKA: Interest of a pharmaceutical link between the hospital and the retail pharmacies].
Bidon D; Lecoeur A; Segui E; Seguette N; Le Mercier F; Bauler S
Ann Pharm Fr; 2017 Jan; 75(1):45-53. PubMed ID: 27234455
[TBL] [Abstract][Full Text] [Related]
2. [Outcomes after a 2-year pharmaceutical care program for patients taking vitamin K antagonist therapy? Community pharmacist's perception].
Mongaret C; Lepage C; Aubert L; Lestrille A; Slimano F
Ann Pharm Fr; 2018 Mar; 76(2):114-121. PubMed ID: 29395013
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course].
Conort O; Siguret V; Bourdon O; Nazaraly S; Brignone M; Pons-Kerjean N; Houze S; Laribe Cage S; Berthet F; Golmard JL; Brion F; Tilleul P
Ann Pharm Fr; 2014 Jul; 72(4):287-95. PubMed ID: 24997889
[TBL] [Abstract][Full Text] [Related]
4. [A new support given to patients in retail pharmacies: The "shared checkup of medication"].
Lehmann H
Ann Pharm Fr; 2019 Jul; 77(4):265-275. PubMed ID: 31023556
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of patients' knowledge on their vitamin K antagonist treatment.
Mzoughi K; Zairi I; BenGhorbel F; Ben Kilani M; Kamoun S; Ben Moussa F; Fennira S; Kraiem S
Tunis Med; 2018 Mar; 96(3):182-186. PubMed ID: 30325485
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic education of elderly patients under antivitamin - K treatment: evaluation of the program after 5 years].
Thiriat N; Peyron I; Bernard-Charrière S; Monti A; Pariel S; Pautas E
J Pharm Belg; 2014 Sep; (3):30-7. PubMed ID: 25226761
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the knowledge of patients about the management of treatment with anti-vitamin K drugs in the Service of Cardiology of Ouagadougou].
Samadoulougou AK; Naibe DT; Mandi DG; Kabore E; Millogo GR; Yameogo NV; Kologo JK; Tall AT; Toguyeni BJ; Zabsonre P
Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):263-7. PubMed ID: 26275496
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in children participating in a non-selective INR self-monitoring VKA-education programme.
Amedro P; Bajolle F; Bertet H; Cheurfi R; Lasne D; Nogue E; Auquier P; Picot MC; Bonnet D
Arch Cardiovasc Dis; 2018 Mar; 111(3):180-188. PubMed ID: 29100908
[TBL] [Abstract][Full Text] [Related]
9. [Educational and information needs of patients under vitamin K antagonist therapy].
Ben Jeddou K; Ben M'Barka F; Boukhris I; Arfaoui H; Baccar H; Khalfalah N; Ouhachi Z
Rev Med Interne; 2018 Jul; 39(7):546-550. PubMed ID: 29789192
[TBL] [Abstract][Full Text] [Related]
10. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
[TBL] [Abstract][Full Text] [Related]
11. [What are the expectations of coordination and accompaniment of French patients with cancer towards their community pharmacist?].
Hébert G; Minvielle E; Di Palma M; Lemare F
Bull Cancer; 2018 Mar; 105(3):245-255. PubMed ID: 29486920
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.
Pereira de Sousa L; Burba I; Ruperto C; Lattuada L; Barbone F; Di Chiara A
J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):534-40. PubMed ID: 23328227
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and management of antivitamin K overdose in a hospital setting.
Zemouri A; Lin F; Billuart O; Sacco E; Emmerich J; Priollet P; Yannoutsos A
J Med Vasc; 2021 Jul; 46(4):175-181. PubMed ID: 34238512
[TBL] [Abstract][Full Text] [Related]
15. [Therapy education for patients receiving oral anti-coagulants vitamin K antagonists].
Satger B; Blaise S; Fontaine M; Yver J; Allenet B; Baudrant M; Pernod G; Bosson JL
Presse Med; 2009 Dec; 38(12):1780-7. PubMed ID: 19815369
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Computer Application for Retrospective Detection of Vitamin K Antagonist Treatment Imbalance.
Ferret L; Luyckx M; Ficheur G; Chazard E; Beuscart R
J Patient Saf; 2018 Jun; 14(2):115-123. PubMed ID: 27336190
[TBL] [Abstract][Full Text] [Related]
17. [Improvement of knowledge of patients treated with an oral anticoagulant after a pharmaceutical interview at the hospital].
Singh S; Bottois C; Benmelouka C; Gutermann L; Conort O
Ann Pharm Fr; 2022 Jul; 80(4):467-477. PubMed ID: 34481785
[TBL] [Abstract][Full Text] [Related]
18. [Use and monitoring of vitamin K antagonists in everyday medical practice. French results of the international ISAM study of patients with nonvalvular atrial fibrillation].
Mahé I; Bal dit Sollier C; Duru G; Lamarque H; Bergmann JF; Drouet L
Presse Med; 2006 Dec; 35(12 Pt 1):1797-803. PubMed ID: 17159730
[TBL] [Abstract][Full Text] [Related]
19. [Vitamin K antagonist overdose induced blindness in an infant: an argument for a therapeutic educational program].
Bui Quoc E; Bonnet D; Bajolle F
Arch Pediatr; 2012 Jan; 19(1):22-6. PubMed ID: 22169573
[TBL] [Abstract][Full Text] [Related]
20. Approaches to optimal dosing of vitamin K antagonists.
Witt DM
Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
